204 related articles for article (PubMed ID: 37090052)
1. Autoimmune cerebellar ataxia associated with anti-Purkinje cells antibodies: the next frontier of neuroimmunology.
Zhang W; Ren H; Ren X; Fang F; Guan H
Ann Transl Med; 2023 Apr; 11(7):285. PubMed ID: 37090052
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China.
Liu M; Ren H; Zhu Y; Fan S; Bai L; Wang J; Cui L; Guan H
Cerebellum; 2023 Jun; 22(3):379-385. PubMed ID: 35618871
[TBL] [Abstract][Full Text] [Related]
3. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():168. PubMed ID: 26377319
[TBL] [Abstract][Full Text] [Related]
4. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():167. PubMed ID: 26377184
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution.
Kudo A; Yaguchi H; Tanaka K; Kimura A; Yabe I
J Neurol; 2024 Jan; 271(1):553-563. PubMed ID: 37610447
[TBL] [Abstract][Full Text] [Related]
6. 'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():166. PubMed ID: 26377085
[TBL] [Abstract][Full Text] [Related]
7. Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature.
Jarius S; Bräuninger S; Chung HY; Geis C; Haas J; Komorowski L; Wildemann B; Roth C
J Neuroinflammation; 2022 Jul; 19(1):196. PubMed ID: 35907972
[TBL] [Abstract][Full Text] [Related]
8. Nonparaneoplastic autoimmune cerebellar ataxias.
Joubert B; Honnorat J
Curr Opin Neurol; 2019 Jun; 32(3):484-492. PubMed ID: 30694927
[TBL] [Abstract][Full Text] [Related]
9. Update in Autoimmune Movement Disorders: Newly Described Antigen Targets in Autoimmune and Paraneoplastic Cerebellar Ataxia.
Garza M; Piquet AL
Front Neurol; 2021; 12():683048. PubMed ID: 34489848
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia.
Damato V; Papi C; Spagni G; Evoli A; Silvestri G; Masi G; Sabatelli E; Campetella L; McKeon A; Andreetta F; Riso V; Monte G; Luigetti M; Primiano G; Calabresi P; Iorio R
Eur J Neurol; 2022 Feb; 29(2):564-572. PubMed ID: 34710286
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen.
Jaeckle KA; Graus F; Houghton A; Cardon-Cardo C; Nielsen SL; Posner JB
Ann Neurol; 1985 Nov; 18(5):592-600. PubMed ID: 2416270
[TBL] [Abstract][Full Text] [Related]
12. Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges.
Hadjivassiliou M; Manto M; Mitoma H
Brain Sci; 2022 Aug; 12(9):. PubMed ID: 36138901
[TBL] [Abstract][Full Text] [Related]
13. Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses.
Muñiz-Castrillo S; Vogrig A; Ciano-Petersen NL; Villagrán-García M; Joubert B; Honnorat J
Cerebellum; 2022 Aug; 21(4):573-591. PubMed ID: 35020135
[TBL] [Abstract][Full Text] [Related]
14. Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia.
Jarius S; Martínez-García P; Hernandez AL; Brase JC; Borowski K; Regula JU; Meinck HM; Stöcker W; Wildemann B; Wandinger KP
J Neuroinflammation; 2013 Jan; 10():7. PubMed ID: 23320754
[TBL] [Abstract][Full Text] [Related]
15. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
Yshii L; Bost C; Liblau R
Front Immunol; 2020; 11():991. PubMed ID: 32655545
[TBL] [Abstract][Full Text] [Related]
16. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
17. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options.
Dropcho EJ
Ann Neurol; 1995 May; 37 Suppl 1():S102-13. PubMed ID: 8968221
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against eukaryotic translation elongation factor 1 delta in two patients with autoimmune cerebellar ataxia.
Guo L; Ren H; Fan S; Chao X; Liu M; Guan H; Wang J
Front Immunol; 2023; 14():1289175. PubMed ID: 38332912
[TBL] [Abstract][Full Text] [Related]
20. [Immune-Mediated Cerebellar Ataxias].
Mitoma H
Brain Nerve; 2021 May; 73(5):611-619. PubMed ID: 34006695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
